Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.9K Sell
47
-7
-13% -$1.04K ﹤0.01% 503
2026
Q1
$5.03K Sell
54
-4
-7% -$354 ﹤0.01% 617
2025
Q4
$4.66K Buy
58
+16
+38% +$1.34K ﹤0.01% 523
2025
Q3
$4.1K Hold
42
– – ﹤0.01% 495
2025
Q2
$2.93K Buy
+42
New +$2.4K ﹤0.01% 520

Other funds holding ACLS

Kilter Group's ACLS Position: Q2 2026 in Review

Kilter Group reduced its Axcelis (ACLS) stake by 13% in Q2 2026, selling an estimated $1.04K and leaving 47 shares worth $8.9K. The position accounts for ﹤0.01% of the portfolio, ranked #503.

Kilter Group first reported a position in ACLS in Q2 2025 and has held it in 5 quarters since. 443 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Kilter Group held 47 shares of Axcelis worth $8.9K as of Q2 2026.
  • Kilter Group sold 7 Axcelis shares in Q2 2026, an estimated $1.04K.
  • Axcelis made up ﹤0.01% of Kilter Group's portfolio in Q2 2026, its #503 holding.
  • Kilter Group first reported a position in Axcelis in Q2 2025 and has held it in 5 quarters since.
  • 443 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Kilter Group's 13F filing for Q2 2026, filed 11 Aug 2026.